(Q42664210)

4 November 2017

Inter-gene correlation on oligonucleotide arrays: how much does normalization matter? (English)

1 reference

4 November 2017

David L Gold

1

1 reference

PubMed ID

16078863

4 November 2017

Jing Wang

series ordinal

2

1 reference

PubMed ID

16078863

4 November 2017

Kevin R Coombes

series ordinal

3

1 reference

4 November 2017

1 January 2005

1 reference

Molecular Diagnosis and Therapy

4 November 2017

1 reference

4 November 2017

5

1 reference

4 November 2017

4

1 reference

4 November 2017

271-279

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500314

4 November 2017

0 references

cites work

Genetic polymorphisms of estrogen receptor-alpha: possible implications for targeted osteoporosis therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Nicotine metabolism and CYP2A6 allele frequencies in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Nicotine metabolism defect reduces smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Genetic variation of CYP2A6, smoking, and risk of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Pharmacogenetic investigation of smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

The genetic basis for smoking behavior: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

A meta-analytic review of the CYP2A6 genotype and smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Association of metabolic gene polymorphisms with tobacco consumption in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Elucidating the role of genetic factors in smoking behavior and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

The genetic determinants of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Nicotine: from molecular mechanisms to behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

Polymorphic CYP2A6 and its clinical and toxicological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

7 January 2021

Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

7 January 2021

The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

7 January 2021

Twenty one novel single nucleotide polymorphisms (SNPs) of the CYP2A6 gene in Japanese and Caucasians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500314

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500314

1 reference

4 November 2017

1 reference